Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



EFSA publishes report that finds few benefits for infant formulas and other milks

By Shane Starling+

Last updated on 31-Jan-2014 at 12:32 GMT2014-01-31T12:32:55Z

EFSA publishes report that finds few benefits for infant formulas and other milks

Infant formulas fortified with nutrients like prebiotics and probiotics and omega-3s do not provide, “a clear benefit as compared to control formula”, says a report published this week by the European Food Safety Authority (EFSA).

The report , commissioned by the European Commission and compiled by Pallas Health Research & Consultancy in the Netherlands, scanned literature to draw conclusions for infant formula (0-6 months); follow-on milks (6-12 months) and children’s milks (12-36 months). It will inform an opinion EFSA itself is set to produce in the near future.*

“Results showed no disadvantage nor a clear benefit on health or nutrient status of infant formula with reduced protein content,” it concluded.

“Publications on infant formula supplemented with long chain polyunsaturated fatty acids, pre/probiotics, nucleotides, cholesterol, β-palmitate, palm oil and selenium did not show a clear benefit as compared to control formula.”

“Modification of iron or lactose content of infant formulae did not affect iron status or growth, respectively.”

“Results on comparisons of formula with breast milk showed that growth velocity was higher among formula-fed infants than for breast fed infants, but no further significant differences in clinical outcomes were observed,” the report said.

Breast milk lobby welcomes results

The conclusions were welcomed by the UK-based pro-breast feeding group, Baby Milk Action. Policy director Patti Rundall, OBE, told us, We are pleased that EFSA found no evidence that the formulas for toddlers were needed, but more than that, we do need to be looking at the inherent risks of all these products and their role in increasing childhood obesity.” 

She added: It’s critically important that EFSA carries out this work - and ensures that the whole  process is kept entirely free from commercial influence.”  

Patti Rundall, OBE, says it is important, "the process is kept entirely free from commercial influence.”  

She said, “a predominance of industry funded research” had damaged research quality in the area.

“It also impacts on health professionals’ knowledge, on policy makers and ultimately the information that is disseminated to the public.”

Infant formula producers were not available for comment at the time of publication.

The opinion followed a toddler milk-focused opinion  from October last year, where EFSA’s Panel on Dietetic Products, Nutrition and Allergies (NDA) acknowledged that toddler intakes of nutrients like alpha-linolenic acid (ALA), docosahexaenoic acid (DHA), iron, vitamin D and iodine were a concern in some European countries but it found toddler or growing up milks were not the way to bridge such deficiencies.

“No unique role of young-child formulae with respect to the provision of critical nutrients in the diet of infants and young children living in Europe can be identified, so that they cannot be considered as a necessity to satisfy the nutritional requirements of young children when compared with other foods that may be included in the normal diet of young children (such as breast milk, infant formulae, follow-on formulae and cow’s milk),” the NDA said.

Infant nutrient deficiencies (or not)

The new report also scrutinised nutrient deficiencies concluding somewhat differently that, in general, good peer-reviewed data on nutrient deficiencies in infants are scarce.”

“Reasons for differences in prevalence of deficiencies, besides basic diet, appear to be national supplementation and fortification strategies, different use of cut-off values for defining deficiency, selection bias in study populations and ‘real’ geographic differences.”

Infant formula and follow-on formula are currently regulated under the 2006 EU Directive on infant formulae and follow-on formulae.

Children’s or toddler’s milks, according to the EC, "are promoted as being particularly suitable for young children and, as such, under the current rules, may be considered as foodstuffs for particular nutritional uses."

Formula backgrounder

In late 2011 the German Federal Institute for Risk Assessment (BfR) concluded toddler’s milks were no better nutritionally than regular cow’s milk for over-1s.

It said the protein manipulation and addition of fatty acids, vitamins and minerals in infant drinks did not deliver nutritional bonuses to infants compared to normal dairy milk.

When it commissioned the report, the EC said EFSA's opinion should determine the, "necessity of growing-up milks' to satisfy the nutritional requirements of young children and, if considered appropriate, advise the Commission with respect to the appropriate age range and the essential composition of 'growing-up milks'."

Roger Clarke, president of Specialised Nutrition Europe (SNE), which counts formula manufacturers among its membership, previously said the group would welcome EFSA’s opinion and, “the EU model being used at international level”.

*Correction: This story has been amended to clarify that the report, whilst published by EFSA, was produced by a third party, Pallas Health Research & Consultancy. It will inform EFSA's own opinion on the matter which is yet to come.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars